At Ketavita Wellness Clinic, we specialize in treatment-resistant depression—providing hope and breakthrough treatment options when conventional approaches haven’t delivered the relief you need. Our evidence-based therapies work through different mechanisms than traditional antidepressants, offering new pathways to recovery.
Located in Wyckoff, New Jersey, our clinic provides compassionate, specialized care for individuals who continue struggling with depression despite multiple treatment attempts. We understand the frustration and hopelessness that can accompany treatment-resistant depression, and we’re committed to helping you find effective solutions through advanced therapeutic approaches.
Every patient receives personalized care based on their unique treatment history, symptoms, and individual circumstances. We take time to understand what you’ve tried, what hasn’t worked, and develop targeted treatment strategies designed to break through treatment resistance and achieve meaningful symptom improvement.
Ketavita Wellness Clinic offers specialized treatments specifically proven effective for treatment-resistant depression:
IV Ketamine Therapy provides rapid-acting relief through a novel mechanism. Unlike traditional antidepressants that work on serotonin pathways and take weeks to show effects, ketamine acts on the glutamate system, promoting neuroplasticity and often providing improvement within hours to days. Research shows response rates up to 70% in treatment-resistant depression—significantly higher than conventional antidepressants.
IM Ketamine Therapy delivers ketamine through intramuscular injection, offering similar therapeutic benefits with a slightly different administration method. This may be appropriate based on individual factors and clinical considerations.
SPRAVATO® is the first and only FDA-approved medication specifically indicated for treatment-resistant depression. You must have tried at least two different antidepressants without adequate response to qualify for SPRAVATO® treatment. As an FDA-approved treatment, it may be covered by insurance when medical necessity criteria are met.
TMS Therapy uses focused magnetic fields to stimulate underactive brain regions involved in mood regulation. This non-invasive, FDA-approved treatment for treatment-resistant depression doesn’t require anesthesia and produces no systemic side effects. TMS may also be covered by insurance for treatment-resistant depression when appropriate criteria are met.
Each treatment works through unique mechanisms that differ fundamentally from conventional antidepressants. The right option depends on your specific situation, treatment history, insurance coverage, and personal preferences.
Treatment-resistant depression occurs when depression doesn’t respond adequately to at least two different antidepressant medications tried at appropriate doses for sufficient duration. This affects approximately one-third of people with major depressive disorder, making it a common yet challenging condition requiring specialized treatment approaches.
If you’ve tried multiple antidepressants without significant improvement, experienced intolerable side effects that prevented continuing treatment, or found that medications provided only partial relief or temporary improvement before symptoms returned, you may have treatment-resistant depression. This isn’t a failure on your part—it simply means your depression requires a different therapeutic strategy.
Treatment-resistant depression significantly impacts every aspect of life. The persistent symptoms despite treatment attempts can create profound frustration, affect relationships and work performance, reduce quality of life, and sometimes lead to feelings of hopelessness about recovery. However, treatment resistance doesn’t mean untreatable. It means you need approaches that work through different mechanisms than conventional antidepressants.
Several factors can contribute to treatment resistance. Your depression may involve biological factors that don’t respond to traditional serotonin-based antidepressants, requiring medications that work through different neurotransmitter systems. Undiagnosed co-occurring conditions like anxiety disorders, bipolar disorder, PTSD, or substance use issues can complicate treatment and reduce antidepressant effectiveness.
Medical conditions including thyroid disorders, chronic pain, or inflammatory conditions may interfere with depression treatment. Medication factors such as inadequate dosing, insufficient treatment duration, or drug interactions can also prevent adequate response to antidepressants.
Understanding why your depression has been resistant to treatment helps guide more effective therapeutic strategies. During your evaluation, we conduct a comprehensive assessment to identify factors that may be contributing to treatment resistance and develop approaches specifically targeted to overcome these barriers.
Our specialized treatments bypass the neurotransmitter systems targeted by traditional antidepressants, working through entirely different pathways. This explains why they can be effective when conventional medications have failed.
Ketamine and SPRAVATO® act as NMDA receptor antagonists affecting the glutamate system—the brain’s most abundant excitatory neurotransmitter. This modulation promotes rapid neuroplasticity, the formation of new neural connections that help reset disrupted brain patterns associated with depression. The unique mechanism explains the rapid onset of action, with many patients experiencing relief within hours to days rather than the weeks required for traditional antidepressants.
TMS therapy directly stimulates specific brain regions that show reduced activity in depression, particularly the left dorsolateral prefrontal cortex. The focused magnetic pulses enhance neural activity in these underactive areas, helping restore normal communication patterns between brain regions involved in mood regulation. Unlike systemic medications, TMS targets specific brain circuits with precision.
These novel mechanisms represent fundamentally different approaches to treating depression. They don’t simply adjust the same neurotransmitter systems that haven’t provided adequate relief—they work through entirely separate pathways, offering genuine alternatives when traditional treatments have failed.
Your treatment-resistant depression journey at Ketavita begins with a comprehensive evaluation. We’ll review your complete depression history including when symptoms began, all previous treatments attempted and their results, medications you’re currently taking, co-occurring medical or psychiatric conditions, and how depression affects your daily functioning.
This thorough assessment helps us understand your treatment resistance and determine which specialized approach offers the best chance of success. We develop a personalized treatment plan that considers your unique history and circumstances.
For ketamine therapy, treatment typically begins with an initial series of 6-8 infusions over 2-3 weeks. Your first session includes preparation, the 40-minute infusion with continuous monitoring, and recovery time in our office. You’ll need someone to drive you home, as you cannot drive for 24 hours after treatment. Many patients notice improvement after the first few sessions, with effects building over the treatment series.
For SPRAVATO®, you self-administer the nasal spray under our direct medical supervision, then remain under observation for at least two hours. Treatment begins with twice-weekly sessions during the induction phase, gradually transitioning to less frequent maintenance dosing based on your response. You must continue taking an oral antidepressant alongside SPRAVATO® as required by FDA approval.
For TMS therapy, you’ll receive 20-40 minute sessions five days per week for 4-6 weeks. The magnetic stimulation creates a tapping sensation on your scalp, but the procedure doesn’t require sedation or recovery time. You can drive immediately after and return to normal activities.
Response varies among individuals, but the key difference with these treatments is that when they work, effects often appear more rapidly than conventional antidepressants. We monitor your progress closely using standardized assessment tools, tracking symptom changes and adjusting treatment protocols to optimize your response.
Our specialized treatments are specifically designed for treatment-resistant depression. You may be a candidate if you meet certain criteria.
For IV and IM ketamine therapy, candidacy typically includes having tried at least two different antidepressant medications at adequate doses without sufficient improvement, continuing to experience significant depressive symptoms that interfere with functioning, and being medically appropriate for ketamine treatment based on cardiovascular and other health factors.
For SPRAVATO®, FDA approval specifically requires documented treatment-resistant depression with inadequate response to at least two different antidepressant trials. You must also be able to continue an oral antidepressant during SPRAVATO® treatment and comply with the required observation period after each session.
For TMS therapy, you should have tried at least two antidepressant medications without adequate benefit, have no contraindications such as metallic implants in or near the head, and be able to commit to daily treatment sessions for 4-6 weeks.
Certain medical conditions may affect treatment candidacy. We conduct thorough health screenings to ensure safety and appropriateness. The best way to determine if you’re a candidate is through a personal consultation where we can assess your individual situation and recommend the approach most likely to help you achieve breakthrough improvement.
Treatment-resistant depression requires specialized expertise and evidence-based protocols. We stay current with the latest research and follow treatment approaches proven effective in clinical studies specifically for treatment-resistant depression.
Safety is paramount in our treatment protocols. All treatments are administered by licensed medical professionals with appropriate monitoring and emergency preparedness. We conduct comprehensive health screenings before treatment, provide continuous monitoring during sessions, and ensure proper follow-up care.
We recognize that effective care for treatment-resistant depression often requires a comprehensive approach. While our specialized treatments provide rapid symptom relief through novel mechanisms, we encourage maintaining other aspects of mental health care including psychotherapy when beneficial, coordination with your prescribing psychiatrist, lifestyle modifications that support mental health, and strong support systems.
Patient education is central to our approach. We ensure you understand why previous treatments may not have worked, how our treatments offer different mechanisms of action, what to expect during your treatment journey, and realistic timelines for improvement. We’re always available to answer questions and provide support throughout your care.
Insurance coverage varies significantly depending on the treatment and your specific insurance plan. SPRAVATO® and TMS therapy are more likely to be covered by insurance as both are FDA-approved specifically for treatment-resistant depression. However, coverage varies by plan, and prior authorization is typically required.
We strongly recommend contacting your insurance provider before beginning treatment to verify coverage, understand prior authorization requirements, confirm your out-of-pocket costs, and ensure you meet medical necessity criteria for coverage.
IV and IM ketamine therapy represent off-label use for depression and are typically not covered by insurance. We provide transparent pricing: IV ketamine for depression is $395 per session. A typical initial treatment series involves 6-8 sessions, and we can discuss package options and payment plans.
We view treatment-resistant depression care as an important investment in your health and quality of life. Living with persistent depression despite multiple treatment attempts is extraordinarily challenging. While cost considerations are real, we believe access to potentially life-changing treatment shouldn’t be limited by financial barriers alone.
For all treatments, we can provide documentation for possible out-of-network reimbursement or health savings account submissions. We’re committed to working with you to make effective treatment as accessible as possible.
If you’ve tried multiple antidepressants without achieving the relief you need, specialized treatment for TRD at Ketavita Wellness Clinic offers new hope. Our advanced therapies work through entirely different mechanisms than conventional antidepressants, providing breakthrough options when traditional approaches haven’t succeeded.
You don’t have to accept persistent depression as your reality. Novel treatments specifically proven effective for treatment-resistant depression can help you achieve meaningful improvement and reclaim your quality of life.
Taking the first step starts with a conversation. Contact us today to schedule your comprehensive evaluation and learn how our specialized treatment-resistant depression therapies can help you break through treatment resistance and find the relief you deserve.
Cepeda MS, Williamson T, Kern DM, Defalco F. Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials. Neuropsychopharmacology. 2024.
https://www.nature.com/articles/s41386-024-02044-5
Havlik JL, Wahid S, Teopiz KM, et al. Recent Advances in the Treatment of Treatment-Resistant Depression: A Narrative Review of Literature Published from 2018 to 2023.
Mental Health Conditions
Conditions Treated
365 Franklin Avenue, Wyckoff, NJ 07481